TSHA Kronos AI forecast
A 30-trading-day price forecast for Taysha Gene Therapies Inc. (TSHA) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Taysha Gene Therapies Inc. at $5.49 on 2026-12-08, +29.2% from the last close of $4.25 on 2026-10-27. Eight out of ten sampled paths end between $5.24 and $5.91, and 8 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of TSHA
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $4.22 | $4.13 | $4.60 |
| 2026-11-10 | $4.42 | $4.22 | $4.48 |
| 2026-11-17 | $4.72 | $4.45 | $5.14 |
| 2026-11-24 | $5.17 | $4.75 | $5.59 |
| 2026-12-01 | $5.33 | $5.01 | $5.70 |
| 2026-12-08 | $5.49 | $5.24 | $5.91 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for TSHA?
- Kronos AI's median forecast for TSHA is $5.49 in 30 trading days, +29.2% from the last close, with a 10–90% range of $5.24 to $5.91.
- Is the TSHA Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- AMGN — Amgen Inc.
- GILD — Gilead Sciences Inc.
- MRNA — Moderna Inc.
- ARGX — argenx SE American Depositary Shares
- RVMD — Revolution Medicines Inc.
- BIIB — Biogen Inc.